Helicon Health Signs Distribution Agreement with Adherium (ADR)

Helicon Health Signs Distribution Agreement with Adherium (ADR)

Helicon® Health expands remote patient monitoring and virtual ward solutions with announcement of Distribution Agreement with Adherium Limited, a  leader in respiratory eHealth.

London, England – 17th June 2022: Helicon Health a leader in delivering healthcare virtually is pleased to announce it has signed an agreement to distribute and integrate the Hailie® sensor range and cloud data services on behalf of Adherium Limited (“Adherium”; ASX: ADR). Adherium is a leader in respiratory eHealth, remote patient monitoring and virtual ward solutions.

Adherium’s Hailie® smart digital inhaler attaches to a patient’s Asthma or COPD medication  inhaler and connects via the Hailie® app to Helicon’s comprehensive remote patient monitoring platform. The combination creates, for the first time, the most advanced quality of  care for respiratory patients that are on Virtual Wards, at home and in any other remote setting. Adherium’s Hailie® sensors monitor medication adherence and the new, next generation sensors, provide actionable data about technique and physiology for the clinical   team to make timely decisions on patient care.

Helicon Health is a medical technology development company, an NHS-focused contract  research partner and specialised medical device accelerator. Helicon Health was originally spun-out from the UCL Centre for Health Informatics and Multi Professional Education (CHIME). Helicon Health is supporting integrated care systems in the development of  “learning health systems” by enabling the ethical collection of real-world data for analysis     and interpretation for real world evidence to inform translation into better outcomes for patients and more effective use of scarce resources.

Initially founded to support the care of those that require at home care for conditions such as cardiovascular disease, cancer, diabetes and dementia, Helicon has accelerated and expanded its offering for respiratory, paediatric, neo-natal, fetal and perinatal medicine and trauma networks through partnerships to deliver healthcare virtually.

The signing of this distribution agreement for an initial three-year term follows the recent appointment of Francis White as Vice President of Global Business Development and cements Adherium’s growth strategy to partner with leading players globally across strategically important geographies especially in the USA and UK to expand its footprint and deliver enhanced remote patient care. Tony Bowden, Chief Executive Officer of Helicon Health commented, “This agreement with Adherium marks yet another milestone in our journey towards helping people live longer  healthier lives. Supporting people with understanding and complying with the instructions for use of medications is fundamental to achieving the healthcare outcomes people young  and old and all in between need – whilst at the same time helping health systems gain best  results from scarce resource.”

“This agreement between Helicon Health and Adherium Limited, presents a significant opportunity to better serve the often- overlooked severe Asthma population and give a truly metric driven care pathway for         COPD patients”. “The expertise of the team at Helicon will transform our market access in the UK, give us opportunities in ground-breaking care and accelerate adoption,” said Francis White, Global VP Business Development for Adherium.

About The Hailie® solution

The Hailie® solution includes a suite of integration tools to enable the capture and sharing of health data via mobile and desktop apps, Software Development Kit (SDK) and Application Programming Interface (API) integration tools, and Adherium’s own broad range of sensors connected to respiratory medications. Adherium’s Hailie® solution is designed to provide visibility to healthcare providers of medication use history to better understand patterns in patient respiratory disease.

Enquiries: info@heliconhealth.co.uk


More Helicon News

About the Author
Tony Bowden
As CEO, Director and Shareholder the buck stops with me. I thank all our valued Customers, Partners, Shareholders and Team members for their continued support.
Share this post
Share This